Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2024

Type / Class
Equity / Class 'A' Ordinary Shares
Symbol
TRIB on Nasdaq
Shares outstanding
385,837,333
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MiCo IVD Holdings, LLC 18% $31,252,824 69,450,720 MiCo IVD Holdings, LLC 17 Dec 2024

Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q1 0 $0 -$2,570,471 0
2023 Q4 6,017,301 $2,583,427 -$60,379 $0.43 25
2023 Q3 6,136,275 $4,492,942 -$57,991 $0.74 20
2023 Q2 6,203,359 $5,927,524 -$120,184 $0.95 20
2023 Q1 6,322,223 $5,960,890 -$246,043 $0.94 20
2022 Q4 6,575,585 $6,511,053 -$453,316 $0.99 20
2022 Q3 7,013,813 $7,494,454 -$301,117 $1.07 18
2022 Q2 7,293,307 $8,921,000 -$1,903,060 $1.22 17
2022 Q1 9,017,002 $9,558,000 +$3,817,525 $1.06 18
2021 Q4 5,387,370 $7,700,000 -$285,833 $1.43 17
2021 Q3 5,515,826 $11,909,000 -$396,530 $2.16 20
2021 Q2 5,663,570 $16,647,000 +$630,861 $2.94 26
2021 Q1 5,404,173 $20,322,000 -$2,001,163 $3.76 31
2020 Q4 5,935,793 $22,614,000 -$313,125 $3.81 22
2020 Q3 6,300,475 $12,723,000 -$2,024,499 $2.02 21
2020 Q2 7,280,574 $15,872,000 -$1,212,557 $2.18 24
2020 Q1 8,778,536 $9,657,000 -$1,744,161 $1.10 20
2019 Q4 10,421,414 $10,760,000 -$896,842 $1.03 23
2019 Q3 10,629,465 $12,858,000 -$2,017,166 $1.21 24
2019 Q2 11,817,237 $20,196,000 -$4,061,095 $1.65 30
2019 Q1 13,086,618 $37,292,000 -$263,164 $2.85 35
2018 Q4 13,207,308 $30,239,000 -$4,288,060 $2.29 35
2018 Q3 14,301,903 $57,202,000 -$1,180,790 $4.00 43
2018 Q2 14,578,989 $72,890,000 -$3,282,605 $5.00 42
2018 Q1 15,232,918 $78,447,079 +$1,820,197 $5.15 44
2017 Q4 14,924,359 $76,044,039 +$1,681,413 $5.10 42
2017 Q3 14,524,418 $81,482,846 -$2,328,511 $5.61 51
2017 Q2 14,929,650 $89,576,500 +$3,730,839 $6.00 52
2017 Q1 15,728,720 $93,738,571 -$476,505 $5.96 62
2016 Q4 15,753,386 $108,985,984 -$42,814,279 $6.92 67
2016 Q3 16,644,625 $220,116,744 -$2,676,769 $13.22 76
2016 Q2 16,872,606 $191,194,968 -$4,958,105 $11.34 79
2016 Q1 17,298,667 $201,618,632 +$108,770 $11.66 78
2015 Q4 17,279,232 $203,291,000 -$13,703,419 $11.76 80
2015 Q3 18,447,182 $211,037,011 -$4,320,965 $11.44 92
2015 Q2 17,535,838 $316,682,561 +$27,816,315 $18.06 91
2015 Q1 15,736,897 $301,929,686 +$11,583,352 $19.25 88
2014 Q4 15,193,426 $266,077,564 +$18,863,865 $17.51 91
2014 Q3 14,070,367 $256,965,851 +$1,941,076 $18.27 93
2014 Q2 13,789,099 $317,567,580 +$4,354,645 $23.03 92
2014 Q1 13,327,175 $322,994,594 +$21,079,034 $24.23 79